Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07740291) titled 'Tirzepatide Impact Assessment Study' on July 28.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Texas Tech University
Condition:
Obesity & Overweight
Cardiometabolic Health Indicators
Addiction
Eating Disorders
Mental Health
Intervention:
Drug: GLP-1 Receptor Agonist Therapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 2, 2025
Target Sample Size: 27
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/N...